In the Valproic acid-induced autism spectrum disorder model of rats, oral administration of 20, 40, and 80 mg/kg of BM methanolic extract for 20 days decreased the inflammation in the hippocampus and prefrontal cortex by decreasing the IL-1β, IL-6, and TNF-α levels dose-dependently. This evidence concerns the gene TNF and autism spectrum disorder.